Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Donald Durden

    TitleProfessor
    SchoolUniversity of California, San Diego
    DepartmentPediatrics
    Address9500 Gilman Drive #0815
    CA La Jolla 92093
    Phone858-534-3355
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      A Phase I study of a dual PI3K/BRD4 inhibitor, SF1126 in the treatment of hepatocellular carcinoma | IDE: 74,551
      NIH R01FD005113Sep 30, 2016 - Aug 31, 2020
      Role: Principal Investigator
      Maximizing cancer synthetic lethality using dual PI-3K/PARP inhibitors
      NIH R41CA206859Sep 22, 2016 - Sep 19, 2017
      Role: Principal Investigator
      Maximal MYC control using dual PI-3K/BRD4 (kinase/epigenetic) inhibitors
      NIH R41CA192656Apr 8, 2015 - Mar 31, 2016
      Role: Principal Investigator
      Phase 2 Study of Poly-ICLC in the Treatment of Pediatric Low Grade Gliomas
      NIH R01FD004385Sep 5, 2014 - Jul 31, 2018
      Role: Principal Investigator
      Role of Syk and Rac2 in regulation of HIF1alpha and neovascularization.
      NIH R21HL091385Jul 1, 2009 - Jun 30, 2011
      Role: Principal Investigator
      Role of Rac2 in Development and Function of Blood Cells
      NIH P01HL069974Apr 22, 2002 - Mar 31, 2008
      Role: Co-Investigator
      Vascular targeted pan PI-3 kinase inhibitor prodrug, SF1126 for glioma therapy
      NIH R01CA094233Dec 1, 2001 - Mar 31, 2013
      Role: Principal Investigator
      Vascular targeted pan PI-3kinase inhibitor prodrug, SF1126 for glioma therapy.
      NIH R56CA094233Dec 1, 2001 - Jun 30, 2009
      Role: Principal Investigator
      Biology and Therapy of High Risk Neuroblastoma
      NIH P01CA081403Jul 6, 2000 - May 31, 2015
      Role: Co-Investigator
      PHASE II STUDY FOR TREATMENT OF PEDIATRIC BRAIN TUMORS
      NIH R01CA075637Sep 15, 1997 - Jul 31, 2000
      Role: Principal Investigator